Assessing Awareness and Information Sources of Newly LaunchedDrugs Among Healthcare Providers in Primary and SecondaryHospitals of Sialkot
Abstract
To compare the level of awareness of new drug Lefamulin with healthcare providers in primary and secondary hospitals in Sialkot and determine the main sources of information that affect the awareness of this drug, as a case.
Cross sectional survey was carried out on healthcare providers working in primary and secondary hospitals in Sialkot. The data on awareness of Lefamulin and the source of information about the availability of Lefamulin was collected with the help of a structured questionnaire. The data were examined to identify the level of awareness, the differences among professionals and the most common information channels which were used.
Out of 44 respondents, 43.18% reported being fully aware of Lefamulin, 25.00% were somewhat aware but required additional information, and 31.82% were unaware of the drug. Out of 18 responses, consultants demonstrated the highest level of awareness (44.44%), while out of 4 responses, 2 surgeons exhibited the awareness while 2 were unaware. Among information sources, pharmaceutical sale representatives were the most influential (used by 65.91% of respondents), followed by professional conferences or seminars (11.36%) and colleagues or peers (6.82%). Junior doctors and physicians relied more heavily on pharmaceutical sales representatives, while consultants utilized a broader range of sources.
The study reveals significant disparities in awareness levels and reliance on pharmaceutical representatives for information about the newly launched medicines. Strategies such as enhanced use of professional conferences, medical journals, and digital platforms are recommended to bridge gaps, particularly for junior doctors and rural providers. Future strategies should focus on diversifying information channels to ensure equitable access to updated drug information across all healthcare sectors.
How to Cite This Article
Rajpoot NR, Eatsham MU, Hussain S, Aslam U, Javed M, Hadi A. Assessing Awareness and Information Sources of Newly LaunchedDrugs Among Healthcare Providers in Primary and SecondaryHospitals of Sialkot. J Pak Soc Intern Med. 2025;6(3):268–272. doi:10.70302/jpsim.v6i3.2550
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Fickweiler F, Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review. BMJ Open. 2017;7(9):e016408.
- Mulinari S. Unhealthy marketing of pharmaceutical products: an international public health concern. J Public Health Policy. 2016;37(2):149-59.
- Dar T. Effectiveness of promotional tools used by medical representatives to generate product prescriptions from doctors with respect to Pakistan’s pharmaceutical industry [dissertation]. Pakistan; 2021.
- Sridhar S, Francis S, Rao PGM. Provision of clinical pharmacy education and services by RAK college of pharmaceutical sciences, Ras Al Khaimah, UAE. Arch Pharm Pract. 2014;4(3):133-6..
- Raj GM, Raveendran R. Introduction to basics of pharmacology and toxicology: Volume 1: General and molecular pharmacology: principles of drug action. Singapore: Springer; 2019.
- Khowaja RH, Feroz A. Unethical pharmaceutical marketing in Pakistan: a systematic review. J Pharm Health Serv Res. 2020;11(1):55-60.
- Gul R, Saeed H, Saleem Z, Rasool F, Hashmi FK, Islam M, et al. Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors. BMC Med Ethics. 2021;22(1):1-16.
- Oshikoya KA, Oreagba I, Adeyemi O. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria. Pan Afr Med J. 2011;9(1):13.
- Pakenham-Walsh N, Bukachi F. Information needs of health care workers in developing countries: a literature review with a focus on Africa. Hum Resour Health. 2009;7(1):30.
- Turkmani S, Smith RM, Tan A, Kamkong CB, Anderson R, Sakulku S, et al. An evaluation of the introduction of telehealth for remote antenatal and postnatal contacts in Bangladesh and Lao People’s Democratic Republic during the COVID-19 pandemic. PLOS Glob Public Health. 2023;3(5):e0000786.
- Ye J, He L, Beestrum M. Implications for implementation and adoption of telehealth in developing countries: a systematic review of China’s practices and experiences. npj Digital Medicine. 2023;6(1):174.
- Zhang M, Doi L, Awua J, Asare H, Stenhouse R. Challenges and possible solutions for accessing scholarly literature among medical and nursing professionals and students in low-and-middle income countries: a systematic review. Nurse Educ Today. 2023;123:105737.
- Forsetlund L, O'Brien MA, Forsén L, Reinar LM, Okwen MP, Horsley T, et al. Continuing education meetings and workshops: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2021;9(9):CD003030.
- Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med. 2020;382(18):1679-81.
- Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Parikh SV, et al. Improving continuing medical education by enhancing interactivity: lessons from Iran. J Adv Med Educ Prof. 2016;4(2):54-63.
- Gizaw Z, Astale T, Kassie GM. What improves access to primary healthcare services in rural communities? A systematic review. BMC Prim Care. 2022;23(1):313.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.